caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1023100476

Cynthia Di Lauro

PRACTICERMC MEDICAL LLCSee all providers at this practice →
Internal MedicineEstes Park, COI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

CCN 060010
Hospital
CCN 060119
Hospital
CCN 061312
Hospital
REFERRAL NETWORK

Where Cynthia Di Lauro's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SUMMA HEALTH SYSTEM1850
Mark Richards
Diagnostic Radiology · Akron, OH
1220
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Quest Diagnostics Of Pennsylvania, Inc.
Clinical Laboratory · Pittsburgh, PA
64170
VISITING NURSE SERVICE, INC.5277
AKRON GENERAL MEDICAL CENTER51178
J&c Ambulance Service, Inc.
Ambulance Service Provider · North Canton, OH
3537
SUMMA HEALTH SYSTEM1153
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
3,907
Beneficiaries
—
Total drug cost
$285K
Distinct drugs
99
Brand share
18.3%
Top prescribed drugs
Levothyroxine Sodium239 claims
Losartan Potassium166 claims
Amlodipine Besylate164 claims
Omeprazole141 claims
Atorvastatin Calcium132 claims
QUALITY · MIPS · 2024
Final MIPS score
86.1
Quality
74.8
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.47%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.